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Introduction
Yolk sac tumor (YST), also known as endodermal sinus
tumor, is a member of the germ cell tumor (GCT)
group. YSTs are estimated as less than 8% of all primary
intracranial GCTs and usually develop in the midline
at the pineal or suprasellar regions, as do other GCTs.
However, rarely, they may arise from ‘‘ectopic sites’’,
most notably the basal ganglia and thalamus, where
they present ill-defined infiltrations with little to no
mass effect shown on neuroimaging during the early
course of the disease. YSTs involving the bilateral basal
ganglia are exceedingly rare. We report a patient with
bilateral basal ganglia YST in whom conventional mag-
netic resonance imaging (MRI) findings were not spe-
cific, highlighting the difficulty of early diagnosis.
Case Report
A previously healthy and developmentally normal 
7-year-old girl presented with a 2-month history of pro-
gressive left hemiparesis and was evaluated at another
hospital. Physical examination showed left-sided weak-
ness, spasticity, and hyperreflexia. She had no sensory
or cranial nerve deficits. She used to be left-handed
and became right-handed gradually. She had neither
diabetes insipidus nor precocious puberty. Computed
tomography (CT) of the brain demonstrated faint cal-
cification in bilateral basal ganglia. MRI of the brain
demonstrated ill-defined abnormal signal intensity with-
out enhancement in the left caudate head, right inter-
nal capsule, and right basal ganglia (more prominent in
the right globus pallidus and putaman) with a smaller
right cerebral peduncle (Figure 1). Neurodegenerative
or metabolic or autoimmune disease was suspected be-
cause of the bilateral nature of the findings. However,
there was no family history, and the laboratory data did
not support such a diagnosis. Empiric trial of intra-
venous methylprednisolone did not lead to any im-
provement. The patient had a hemiparetic gait and
needed assistance with ambulation. She received
rehabilitation and was discharged for follow-up.
Brain MRI was performed again 6 months later
and demonstrated enlarged left caudate nucleus and
progressive atrophy of right cerebral peduncle. On T2-
weighted images, the hyperintense lesions of the right
internal capsule and basal ganglia had become more
heterogeneous compared with the previous examina-
tion (Figure 2).
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Three months later, the patient had developed
additional symptoms including gradual onset right
hand tremor and weakness, cognitive decline, speech
and language regression, and difficulty in swallowing.
Brain MRI demonstrated a huge tumor mass with
internal hemorrhage and perifocal edema, 5 cm in
diameter, in the left basal ganglia with midline shift
(Figure 3). Serum biochemistry revealed a raised 
α-fetoprotein (AFP) level of up to 1,649 ng/mL,
whereas the β-human chorionic gonadotropin (β-hCG)
value was normal.
The patient was subsequently brought to our hos-
pital to seek another medical opinion. Craniotomy with
tumor resection was performed at our hospital. Histo-
pathological examination revealed YST without other
GCT component. The tumor cells were immunoreactive
for AFP, glypican-3 and focally for placental alkaline
phosphatase, while they were nonreactive for β-hCG
and podoplanin (D2-40) (Figure 4). Her neurological
function remained unimproved after the operation.
We initiated chemotherapy comprising three courses
of vinblastin, bleomycin, cisplatin and etoposide, and
planned radiation therapy to start at the completion
of this induction therapy.
Discussion
Intracranial GCTs constitute not more than 3% of all
primary brain tumors in Western countries. However,
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Figure 1. Axial magnetic resonance imaging shows: (A) ill-defined abnormal signal intensity in the left caudate head, right internal 
capsule, and right basal ganglia (more prominent in the right globus pallidus and putaman) (arrows) on T2-weighted imaging; and 
(B) a smaller right cerebral peduncle (arrow) on T1-weighted imaging.
A B
Figure 2. Axial magnetic resonance imaging shows: (A) enlarged left caudate nucleus (arrowhead) and more heterogeneous hyper-
intense lesions of the right internal capsule and basal ganglia (arrows) on T2-weighted imaging; and (B) progressive atrophy of the right
cerebral peduncle (arrow) on T1-weighted imaging.
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they are more common in Far Eastern countries and
account for 11.2–14.0% of all primary brain tumors in
Taiwan, Japan and Korea.1–3 The incidence of YST is
estimated as less than 8% of all primary intracranial
GCTs. Intracranial GCTs most commonly occur either
in the pineal or suprasellar region or both. The basal
ganglia is a relatively uncommon location for intracra-
nial GCTs (3.3–18.1%).1,4,5 Most of the reported basal
ganglia GCTs are germinomas or mixed GCTs. Pri-
mary YSTs situated in the basal ganglion are extremely
rare. To the best of our knowledge, this is only the third
reported case of primary YST confined to the basal
ganglia (Table 1).6,7
YST was originally described as a GCT of the ovary
and testis. The histogenesis of extragonadal YST is
thought to be either from primordial germ cells that
have migrated aberrantly during embryonic develop-
ment or from undifferentiated pleuripotent embryonic
cells that have been entrapped into the lateral mesoderm
due to misfolding and misplacement, and then un-
dergo malignant transformation.8,9 Additionally, YST
is often associated with components of other GCTs due
to the same reason that YST is a neoplasm derived from
the pleuripotent stem cells that are susceptible to dif-
ferentiate into other GCTs. Although uncommon, YST
can present outside the midline and exhibit a multifo-
cal growth pattern in the brain. Histopathologically,
YSTs are composed of primitive-appearing epithelial
cells linked to extraembryonic mesoblast and charac-
terized by the presence of embryonic structures resem-
bling the normal fetal yolk sac, Schiller-Duval bodies,
periodic acid Schiff-positive intracellular and extracel-
lular hyaline globules, and AFP immunoreactivity.
The presenting symptoms of intracranial GCTs will
vary depending on the site of origin. Hemiparesis is the
most common symptom in patients with basal ganglia
GCTs, and hemiparesis might occur before neuroimag-
ing can detect a lesion in the basal ganglia. The other
A B
Figure 3. Axial magnetic resonance imaging shows a huge tumor mass with internal hemorrhage and perifocal edema, 5 cm in diame-
ter, in the left basal ganglia with midline shift on: (A) T2-weighted imaging; and (B) T1-weighted imaging.
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Figure 4. Microscopically, the tumor had a reticular growth pattern with: (A) numerous hyaline globules; and (B) α-fetoprotein immunolabeling.
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clinical presentations include mental deterioration,
change of character, sensory disturbance, precocious
puberty, slurring speech, dysarthria, and dysphagia.
Signs of increased intracranial pressure present during
the late stage of the disease if obstructive hydrocephalus
occurs. The clinical course usually progresses slowly,
with the average period between initial symptom onset
(usually hemiparesis) and diagnosis being 1 year and 
8 months (range, 1 month to 4 years and 6 months).10
The CT findings of basal ganglia GCTs are charac-
terized by an irregularly defined, slightly high-density
area without significant mass effect, often with faint
calcification and non-homogeneous contrast enhance-
ment. Basal ganglia GCTs often show only mild inten-
sity changes or just a tiny lesion on MRI in the early
stage. The tumors enlarge during the period of slow
progression of hemiparesis. In the later stage, the
tumors occupy the basal ganglia and show a large, irreg-
ular, heterogeneous enhancing mass with or without a
cystic component. The tumors extend to the regions of
the thalamus and deep hemispheres in later stages of
the disease. Although MRI is the imaging modality 
of choice, the findings are rarely specific enough to dis-
tinguish the different GCT subtypes or to distinguish
GCTs from other tumors. In addition, CT and MRI
findings of ipsilateral hemiatrophy of the cerebral hemi-
sphere and brain stem are highly characteristic of GCTs
of the basal ganglia and thalamus, as the result of
Wallerian degeneration caused by tumor infiltration
into the internal capsule with interruption of thalam-
ocortical connections.11
Our case had bilateral basal ganglia lesions. Bilateral
basal ganglia GCTs are rare; only a few cases have pre-
viously been reported, most of them germinomas.12,13
Diagnosis of bilateral GCTs of the basal ganglia at an
early stage is even more difficult than that of unilat-
eral GCTs of the basal ganglia. The bilateral nature of
the lesions suggest metabolic or neurodegenerative dis-
ease rather than neoplasm, although the involved lesions
are not usually completely symmetrical. Clinically, bilat-
eral progressive paresis may occur concomitantly or
sequentially. On neuroimaging, the presence of ill-
defined, bilateral imaging abnormalities in the absence
of a well-defined mass may suggest this kind of case.
A slowly progressive clinical course and nonspe-
cific subtle findings or ill-defined infiltrations without
space-occupying lesions shown on CT or MRI in the
early stages may lead to a delay in diagnosis. Tumor
markers such as AFP and β-hCG are useful tools for
noninvasive diagnosis. Also, 11C-methionine positron
emission tomography is a technique that is not only
for diagnosis but also for precise localization of biopsy
if there is no overt mass formation.14,15
The outcomes differ among histological subtypes.
In general, intracranial YST is known to entail a poor
prognosis. The highest survival rates are seen in pa-
tients with germinoma or mature teratoma (10-year
survival rate > 90% in both groups); the lowest survival
rates are seen in patients with choriocarcinoma, fol-
lowed by embryonal carcinoma, YST, and mixed GCTs
composed mainly of choriocarcinoma, embryonal car-
cinoma, or YST. Patients with pure intracranial YST
have a 3-year survival of only 33%, even after multi-
disciplinary treatment of operation, radiotherapy, and
chemotherapy.16 However, Kirkove et al17 and Lu and
Chen18 reported long-surviving cases of pineal YST,
treated by a combination of surgery, adjuvant che-
motherapy, and craniospinal irradiation. They empha-
sized that chemotherapy as an adjuvant to surgery
and/or irradiation significantly extended survival.
In conclusion, the present case consisted of a pure
YST in bilateral basal ganglia, which is exceedingly rare.
But GCTs are the most common tumors in the basal
ganglia of children in Far Eastern countries. Early diag-
nosis of basal ganglia GCTs requires special attention
to subtle neuroimaging findings with ipsilateral cerebral
peduncle atrophy, especially in young patients with
characteristic symptoms such as slowly progressive hemi-
paresis, and serial neuroimaging studies should be per-
formed. A progressively enlarging lesion in the basal
ganglia of children implies a tumor, especially a GCT.
Examination of tumor markers and/or 11C-methionine
Table 1. Summary of 3 cases of primary yolk sac tumor confined to the basal ganglia
Authors
Age 
Sex Location
Initial Serum 
Treatment Outcome
(yr) symptoms AFP
Masuzawa et al6 10 M Right Hemiparesis N/A Surgery + radiation Died of disease
(1986) thalamus + BG
Oshita et al7 (1993) 8 F Left BG Hemiparesis Elevated Surgery + radiation + Alive, handicapped
chemotherapy
This case (2010) 7 F Bilateral BG Hemiparesis Elevated Surgery + radiation + Alive, handicapped
chemotherapy
AFP =a-fetoprotein; BG = basal ganglia; N/A = not available.
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positron emission tomography may be helpful for early
diagnosis.
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